Generation of a Nrf2 homozygous knockout human embryonic stem cell line using CRISPR/Cas9
Nuclear factor erythroid 2-related factor 2 (NFE2L2 or Nrf2) is a well-known transcription factor that regulates the expression of a large number of anti-oxidant genes in mammalian cells (J.H. Kim et al., 2014). Here, we generated a homozygous Nrf2 knockout human embryonic stem cell (hESC) line, H9N...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-03-01
|
Series: | Stem Cell Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S187350611630229X |
id |
doaj-7ac2ca88299b4ec69d728c537a569366 |
---|---|
record_format |
Article |
spelling |
doaj-7ac2ca88299b4ec69d728c537a5693662020-11-25T03:17:30ZengElsevierStem Cell Research1873-50612017-03-0119464810.1016/j.scr.2016.12.027Generation of a Nrf2 homozygous knockout human embryonic stem cell line using CRISPR/Cas9So-Jung Kim0Omer Habib1Jin-Soo Kim2Hyo-Won Han3Soo Kyung Koo4Jung-Hyun Kim5Division of Intractable Diseases, Center for Biomedical Sciences, Korea National Institute of Health, Cheongju 28159, Republic of Korea; Department of Program in Cell Biology and Genetics, College of Medicine, Chungbuk National University, Cheongju 361-763, Republic of KoreaCenter for Genome Engineering, Institute for Basic Science (IBS), Seoul 08826, Republic of Korea; Department of Chemistry, Seoul National University, Seoul 08826, South KoreaCenter for Genome Engineering, Institute for Basic Science (IBS), Seoul 08826, Republic of Korea; Department of Chemistry, Seoul National University, Seoul 08826, South KoreaDivision of Intractable Diseases, Center for Biomedical Sciences, Korea National Institute of Health, Cheongju 28159, Republic of KoreaDivision of Intractable Diseases, Center for Biomedical Sciences, Korea National Institute of Health, Cheongju 28159, Republic of KoreaDivision of Intractable Diseases, Center for Biomedical Sciences, Korea National Institute of Health, Cheongju 28159, Republic of Korea; Corresponding author.Nuclear factor erythroid 2-related factor 2 (NFE2L2 or Nrf2) is a well-known transcription factor that regulates the expression of a large number of anti-oxidant genes in mammalian cells (J.H. Kim et al., 2014). Here, we generated a homozygous Nrf2 knockout human embryonic stem cell (hESC) line, H9Nrf2KO-A13, using the CRISPR/Cas9 genome editing method. The Nrf2 homozygous knockout H9 cell line maintains pluripotency, differentiation potential into three germ layers, and a normal karyotype.http://www.sciencedirect.com/science/article/pii/S187350611630229X |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
So-Jung Kim Omer Habib Jin-Soo Kim Hyo-Won Han Soo Kyung Koo Jung-Hyun Kim |
spellingShingle |
So-Jung Kim Omer Habib Jin-Soo Kim Hyo-Won Han Soo Kyung Koo Jung-Hyun Kim Generation of a Nrf2 homozygous knockout human embryonic stem cell line using CRISPR/Cas9 Stem Cell Research |
author_facet |
So-Jung Kim Omer Habib Jin-Soo Kim Hyo-Won Han Soo Kyung Koo Jung-Hyun Kim |
author_sort |
So-Jung Kim |
title |
Generation of a Nrf2 homozygous knockout human embryonic stem cell line using CRISPR/Cas9 |
title_short |
Generation of a Nrf2 homozygous knockout human embryonic stem cell line using CRISPR/Cas9 |
title_full |
Generation of a Nrf2 homozygous knockout human embryonic stem cell line using CRISPR/Cas9 |
title_fullStr |
Generation of a Nrf2 homozygous knockout human embryonic stem cell line using CRISPR/Cas9 |
title_full_unstemmed |
Generation of a Nrf2 homozygous knockout human embryonic stem cell line using CRISPR/Cas9 |
title_sort |
generation of a nrf2 homozygous knockout human embryonic stem cell line using crispr/cas9 |
publisher |
Elsevier |
series |
Stem Cell Research |
issn |
1873-5061 |
publishDate |
2017-03-01 |
description |
Nuclear factor erythroid 2-related factor 2 (NFE2L2 or Nrf2) is a well-known transcription factor that regulates the expression of a large number of anti-oxidant genes in mammalian cells (J.H. Kim et al., 2014). Here, we generated a homozygous Nrf2 knockout human embryonic stem cell (hESC) line, H9Nrf2KO-A13, using the CRISPR/Cas9 genome editing method. The Nrf2 homozygous knockout H9 cell line maintains pluripotency, differentiation potential into three germ layers, and a normal karyotype. |
url |
http://www.sciencedirect.com/science/article/pii/S187350611630229X |
work_keys_str_mv |
AT sojungkim generationofanrf2homozygousknockouthumanembryonicstemcelllineusingcrisprcas9 AT omerhabib generationofanrf2homozygousknockouthumanembryonicstemcelllineusingcrisprcas9 AT jinsookim generationofanrf2homozygousknockouthumanembryonicstemcelllineusingcrisprcas9 AT hyowonhan generationofanrf2homozygousknockouthumanembryonicstemcelllineusingcrisprcas9 AT sookyungkoo generationofanrf2homozygousknockouthumanembryonicstemcelllineusingcrisprcas9 AT junghyunkim generationofanrf2homozygousknockouthumanembryonicstemcelllineusingcrisprcas9 |
_version_ |
1724631845843238912 |